Post Polycythemia Vera Myelofibrosis

specific

Progression of polycythemia vera characterized by decreased erythropoiesis and granulopoiesis, reticulin and collagen fibrosis of the bone marrow, leucoerythroblastic reaction in the peripheral blood, poikilocytosis, tear-drop shaped red blood cells, and splenomegaly.

38

Centers

10

Active Trials

Cancer Funding

Top Centers for Post Polycythemia Vera Myelofibrosis(38)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
High-Volume Research Center
73.2
2
NCI Comprehensive
Active Research Program
67.9
3
NCI Comprehensive
Active Research Program
67.9
4
NCI Comprehensive
Active Research Program
67.9
5
NCI Comprehensive
Active Research Program
67.9
667.9
7
Active Research Program
67.9
8
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
67.9
9
BC CancerVancouver, BC
Active Research Program
67.9
10
NCI Comprehensive
46.0
11
NCI Comprehensive
46.0
12
NCI Comprehensive
46.0
13
NCI Comprehensive
46.0
14
NCI Comprehensive
46.0
1546.0
16
NCI Comprehensive
46.0
17
NCI Comprehensive
46.0
18
NCI Comprehensive
46.0
19
NCI Comprehensive
46.0
20
NCI Clinical
46.0
21
NCI Comprehensive
46.0
22
NCI Comprehensive
46.0
2346.0
24
NCI Comprehensive
46.0
2546.0
2646.0
2746.0
28
NCI Comprehensive
46.0
2946.0
3046.0
3146.0
3246.0
3346.0
3446.0
3546.0
3646.0
3746.0
3846.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →